SRC as a novel therapeutic target fot the treatment of triple negative breast cancer (TNBC)

被引：0
|
作者：
Walsh, S. [1 ]
Tryfonopoulos, D. [2 ,3 ]
Quinn, C. [4 ]
Flanagan, L. [4 ]
Pierce, A. [1 ]
McDermott, E. W. [1 ]
Evoy, D. [1 ]
O'Donovan, N. [2 ]
Crown, J. [2 ,3 ]
Duffy, M. J. [1 ,4 ]
机构：
[1] Univ Coll Dublin, UCD Sch Med & Med Sci, Dublin 2, Ireland
[2] Dublin City Univ, NICB, Dublin 9, Ireland
[3] St Vincents Univ Hosp, Dept Med Oncol, Dublin 4, Ireland
[4] St Vincents Univ Hosp, Dept Pathol & Lab Med, Dublin 4, Ireland
来源：
BRITISH JOURNAL OF SURGERY | 2011年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [31] Triple-negative breast cancer (TNBC) phosphoproteomics
    Gaitero, Sara Fernandez
    Zagorac, Ivana
    Lopez-Acosta, Jose Francisco
    Gomez-Lopez, Gonzalo
    Pisano, David Gonzalez
    Peralta, Javier Munoz
    Manso, Luis
    Alonso, Soledad
    Penning, Renske
    Altelaar, Maarten
    Heck, Albert J. R.
    Quintela-Fandino, Miguel
    CANCER RESEARCH, 2017, 77
  • [32] Biomarkers Expression in Triple Negative Breast Cancer (TNBC)
    Nofech-Mozes, Sharon
    Han, Rachel
    Olkhov-Mitsel, Ekaterina
    Lu, Fang-I
    Plotkin, Anna
    Hanna, Wedad
    Slodkowska, Elzbieta
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 135 - 137
  • [33] Biomarkers Expression in Triple Negative Breast Cancer (TNBC)
    Nofech-Mozes, Sharon
    Han, Rachel
    Olkhov-Mitsel, Ekaterina
    Lu, Fang-I
    Plotkin, Anna
    Hanna, Wedad
    Slodkowska, Elzbieta
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 135 - 137
  • [34] Treatment of triple negative breast cancer (TNBC): current options and future perspectives
    De Laurentiis, M.
    Cianniello, D.
    Caputo, R.
    Stanzione, B.
    Arpino, G.
    Cinieri, S.
    Lorusso, V.
    De Placido, S.
    CANCER TREATMENT REVIEWS, 2010, 36 : S80 - S86
  • [35] Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)
    Lee, Jieun
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [36] Effects of Hsp90 Inhibitors on Patient Derived Triple Negative Breast Cancer (TNBC) Cells: BRCA1 as a Therapeutic Target for TNBC
    Anant, Shrikant
    Ramamoorthy, Prabhu
    Tawfik, Ossama
    Jensen, Roy A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (04) : E6 - E6
  • [37] Androgen receptor (AR): A novel target for radiosensitization in triple-negative breast cancers (TNBC)
    Chandler, Benjamin C.
    Speers, Corey W.
    Zhao, Shuang G.
    Liu, Meilan
    Wilder-Romans, Kari
    Olsen, Eric
    Nyati, Shyam
    Spratt, Daniel
    Wahl, Daniel
    Hayes, Daniel
    Feng, Felix Y.
    Pierce, Lori J.
    CANCER RESEARCH, 2017, 77
  • [38] SLC22A17 as a novel therapeutic target for triple-negative breast cancer
    Kunnumakkara, A. B.
    Thakur, K. K.
    ANNALS OF ONCOLOGY, 2022, 33 : S139 - S139
  • [39] Ganglioside GD2: a novel therapeutic target in triple-negative breast cancer
    Shao, Claire
    Anand, Vivek
    Andreeff, Michael
    Battula, Venkata Lokesh
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2022, 1508 (01) : 35 - 53
  • [40] CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
    Ring, Alexander
    Cu Nguyen
    Smbatyan, Goar
    Tripathy, Debu
    Yu, Min
    Press, Michael
    Kahn, Michael
    Lang, Julie E.
    CANCERS, 2018, 10 (12):
12345